Genzyme gets public backing for $200M expansion

Genzyme is getting some public backing for a $200 million expansion project in the south of Ireland. The Cambridge, MA-based biotech plans to hire about 170 people as it expands its manufacturing and research operations. Ireland has become a key global player in biopharma over the years, hosting a range of manufacturing and lab facilities. Teva announced its own expansion plans for Waterford last month.

- read the story from the International Herald Tribune

Related Articles:
Genzyme--Big Biotech's Stock Report. Report
Genzyme on buyouts: Thanks but no thanks. Report
Boston officials herald big Genzyme expansion. Report

Suggested Articles

Xcovery's ALK inhibitor shrank tumors in 75% of lung cancer patients, compared to 67% for Pfizer's Xalkori, the first FDA-approved drug of that class.

The FDA accepted the regulatory filing for Biogen's once-failed Alzheimer's drug, aducanumab, with plans to decide its fate by March 7, 2021.

Alexion named a chief diversity officer, while COVID-19 vaccine player has two new members of its C-suite.